Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 07/31/15
Due: 07/31/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD) | NCT02014363 | e-Therapeutics PLC | user2@example.com | None | 2013-10-31 | 2015-10-31 | 2016-10-31 | - | - | 2025-07-14 |
| Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects | NCT02054754 | e-Therapeutics PLC | user2@example.com | None | 2014-01-31 | 2014-09-30 | 2015-09-30 | - | - | 2025-07-14 |
| A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours | NCT02423239 | e-Therapeutics PLC | user2@example.com | None | 2015-04-30 | 2016-12-31 | 2017-12-31 | - | - | 2025-07-14 |
| A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours | NCT01489826 | e-Therapeutics PLC | user2@example.com | None | 2012-01-31 | 2015-07-31 | 2016-07-31 | - | - | 2025-07-14 |